(Q44740278)

5 December 2017

Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia (English)

1 reference

5 December 2017

1 reference

1 reference

Kreuter M

1

1 reference

5 December 2017

Woelke K

2

1 reference

5 December 2017

Bieker R

3

1 reference

5 December 2017

Schliemann C

4

1 reference

5 December 2017

Steins M

5

1 reference

5 December 2017

Buechner T

6

1 reference

5 December 2017

Berdel WE

7

1 reference

5 December 2017

Mesters RM

8

1 reference

5 December 2017

31 August 2006

1 reference

5 December 2017

1 reference

5 December 2017

20

1 reference

5 December 2017

1950-1954

1 reference

5 December 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404384

5 December 2017

0 references

cites work

Neuropilins in neoplasms: expression, regulation, and function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Neuropilin-1 on hematopoietic cells as a source of vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

7 January 2021

Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

7 January 2021

Angiogenesis in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

7 January 2021

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404384

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404384

1 reference

5 December 2017

1 reference